FDA Advisory Panel Weighs Galleri Multi‑Cancer Blood Test Today — What You Should Know

The FDA advisory committee is evaluating Galleri, Grail’s blood-based Multi-Cancer Early Detection (MCED) test that screens for more than 50 cancer types from a single blood draw. In a trial of nearly 143,000 p...



























